Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence

Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12052-7. doi: 10.1073/pnas.1120437109. Epub 2012 Jul 9.

Abstract

Cellular senescence is widely believed to play a key role in tumor suppression, but the molecular pathways that regulate senescence are only incompletely understood. By using a secretome proteomics approach, we identified insulin-like growth factor binding protein 3 (IGFBP3) as a secreted mediator of breast cancer senescence upon chemotherapeutic drug treatment. The senescence-inducing activity of IGFBP3 is inhibited by tissue-type plasminogen activator-mediated proteolysis, which is counteracted by plasminogen activator inhibitor 1 (PAI-1), another secreted mediator of senescence. We demonstrate that IGFBP3 is a critical downstream target of PAI-1-induced senescence. These results suggest a role for an extracellular cascade of secreted proteins in the regulation of cellular senescence.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Analysis of Variance
  • Cell Line, Tumor
  • Cellular Senescence / physiology*
  • Culture Media / chemistry
  • DNA Primers / genetics
  • Doxorubicin / pharmacology
  • Enzyme-Linked Immunosorbent Assay
  • Fluorescent Antibody Technique
  • Humans
  • Immunoblotting
  • Immunohistochemistry
  • Insulin-Like Growth Factor Binding Protein 3 / metabolism*
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neoplasms / physiopathology
  • Plasminogen Activator Inhibitor 1 / metabolism*
  • Proteolysis / drug effects*
  • Proteomics / methods
  • RNA, Small Interfering / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stress, Physiological / physiology*
  • Tissue Plasminogen Activator / metabolism
  • Tissue Plasminogen Activator / pharmacology*
  • Tumor Cells, Cultured
  • beta-Galactosidase

Substances

  • Culture Media
  • DNA Primers
  • IGFBP3 protein, human
  • Insulin-Like Growth Factor Binding Protein 3
  • Plasminogen Activator Inhibitor 1
  • RNA, Small Interfering
  • SERPINE1 protein, human
  • Doxorubicin
  • beta-Galactosidase
  • Tissue Plasminogen Activator